The role of oxidative stress in chemical carcinogenesis

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 1, 1998, Pages 289-295

  Klaunig, James E ^a   Xu, Yong ^a   Isenberg, Jason S ^a   Bachowski, Stephen ^a   Kolaja, Kyle L ^a   Jiang, Jiazhong ^a   Stevenson, Donald E ^b   Walborg Jr , Earl F ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dermigen Inc   (United States)

Author keywords

Chemical carcinogenesis; Dieldrin; Free radical oxygen; Liver; Mouse liver carcinogenesis; Oxidative stress

Indexed keywords

ANTIOXIDANT; CARCINOGEN; CELL PROTEIN; DIELDRIN; DNA; LIPID; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; DNA DAMAGE; DNA SYNTHESIS; ENZYME ACTIVITY; GENE EXPRESSION; LIVER INJURY; MEMBRANE STRUCTURE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031956813     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s1289     Document Type: Conference Paper

References (43)

1. Sies H. Oxidative stress: introduction. In: Oxidative Stress: Oxidants and Antioxidants (Sies H, ed). San Diego, CA:Academic Press, 1991;15-22.
2. Parke DV, Ioannides C. Role of cytochrome P-450 in mouse liver tumor production. Prog Clin Biol Res 331:215-230 (1990).
3. Halliwell B. Mechanisms involved in the generation of free radicals. Pathol Biol 44:6-13 (1996).
4. Trush MA, Kensler TW. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic Biol Medicine 10:201-209 (1991).
5. Barber DA, Harris SR. Oxygen free radicals and antioxidants: a review. Am Pharm 34:26-35 (1994).
6. Vuillaume M. Reduced oxygen species, mutation, induction and cancer initiation. Mutat Res 186:43-72 (1987).
7. Rice-Evans C, Burdon R. Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 32:71-130 (1993).
8. Ames BN. Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 221:1256-1264 (1983).
9. Willett WC, MacMahon B. Diet and cancer - an overview. N Enel J Med 310:633-638 (1984).
10. Nelson RL. Dietary iron and colorectal cancer risk. Free Radic Biol Med 12:161-168 (1992).
11. Stevens RG, Nerishi K. Iron and oxidative damage in human cancer. In: Biological Consequences of Oxidative Stress: Implications for Cardiovascular Disease and Carcinogenesis (Spatz L, Bloom AD, eds). New York:Oxford University Press, 1992;138-161.
12. Breimer LH. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol Carcinogenesis 3:188-197 (1990).
13. Chaudhary AK, Nokubo M, Marnett LJ, Blair LA. Analysis of . the malondialdehyde-2′-deoxyguanosine adduct in rat liver DNA by gas chromatography/electron capture negative chemical ionization mass spectrometry. Biol Mass Spectrom 23:457-464 (1994).
14. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 54(Suppl):1890s-1894s (1994).
15. Floyd RA. 8-Hydroxy-2′-deoxyguanosine in carcinogenesis. Carcinogenesis 11:1447-1450 (1990).
16. White AA, Crawford KM, Patt CS, Lad PJ. Activation of soluble guanylate cylase from rat lung by incubation or by hydrogen peroxide. J Biol Chem 251:7304-7312 (1976).
17. 2+ sequestration by the plasma membrane fraction from rat liver. FEBS Lett 163:136-139 (1983).
18. Kerr LD, Inoue J, Verm IM. Signal transduction: the nuclear target. Curr Opin Cell Biol 4:496-501 (1992).
19. Davies KJA. Intracellular proteolytic systems may function as secondary antioxidants defenses: an hypothesis. J Free Radic Biol Medicine 9:155-173 (1986).
20. Storz G, Polla BS. Transcriptional regulators of oxidatlve stress-inducible genes in prokaryotes and eukaryotes. Exper Suppl Basel 77:239-254 (1996).
21. Vellanoweth RL, Suprakar PC, Roy AK. Biology of disease transcription factors in development, growth, and aging. Lab Invest 70:784-799 (1994).
22. Whiteside ST, Goodbourn S. Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localization. J Cell Sci 104:949-955 (1993).
23. Schenk H. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-ΚB and AP-1. Proc. Natl Acad Sci USA 91:1672-1676 (1994).
24. Brawn MK, Chiou WJ, Leach KL. Oxidant-induced activation of protein kinase C in UC1 1MG cells. Free Radic Res 22:23-37 (1995).
25. Ames BN, Gold LS. Animal cancer tests and cancer prevention. Natl Cancer Inst Monogr 12:125-32 (1992).
26. Schulte-Hermann R, Timmermann-Tiener I, Barthel G, Bursch W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50:5127-5135 (1990).
27. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull 49(3):523-544 (1993).
28. Scholz W, Schutze K, Kunz W, Schwarz M. Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules. Cancer Res 50:7015-7022 (1990).
29. Stark AA. Oxidative metabolism of glutathione by gamma-glutamyl transpeptidase and peroxisome proliferation: the relevance to hepatocarcinogenesis. A hypothesis. Mutagenesis 6:241-245 (1991).
30. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3:1-7 (1991).
31. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 358:1-3 (1995).
32. Palozza P, Agostara G, Piccioni E, Bartoli GM. Different role of lipid peroxidation in oxidative stress-induced lethal injury in normal and tumor thymocytes. Arch Biochem Biophys 312:88-94 (1994).
33. WHO. Aldrin and Dieldrin. Environmental Health Criteria 91. Geneva:World Health Organization, 1989;184-199.
34. Thorpe E, Walker AI. The toxicology of dieldrin (HEOD). II: Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, B-BHC and gamma-BHC. Food Cosmet Toxicol 11 (3):433-442 (1973).
35. Baldwin MK. Robinson J. A comparison of the metabolism of HEOD (dieldrin) in the CF1 mouse with that in the CFE rat. Food Cosmet Toxicol 10:333-351 (1972).
36. Hutson DH. Comparative metabolism of dieldrin in the rat (CFE) and in two strains of mouse (CF1 and LACG). Food Cosmet Toxicol 14:577-591 (1975).
37. Kolaja KL, Stevenson DE, Johnson JT, Walborg EF Jr, Klaunig JE. Hepatic effects of dieldrin and phenobarbital in male B6C3F1 mice and Fischer 344 rats: species selective induction of DNA synthesis. Prog Clin Biol Res 391:397-408 (1995).
38. Kolaja KL, Stevenson DE, Johnson JT, Walborg EF Jr, Klaunig JE. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam Appl Toxicol 29:219-228 (1996).
39. Kolaja K, Stevenson DE, Walborg EF Jr, Klaunig JE. Selective dieldrin promotion of hepatic focal lesion in mice. Carcinogenesis 17:1243-1250 (1996).
40. Stohs SJ, Shara MA, Alsharif NZ, Wahba ZZ, Al-Bayati ZAF. 2,3,7,8-TetrachIorodibenzo-p-dioxin-induced hepatoxicity in mice. Toxicol Lett 75:177-183 (1990).
41. Bachowski S, Xu Y, Stevenson DE, Walborg EF Jr, Klaunig JE. Manucript submitted.
42. Stevenson DE, Kehrer JP, Kolaja KL, Walborg EF, Klaunig JE. Effect of dietary antioxidants on dieldrin-induced heparotoxicity in mice. Toxicol Lett 75:177-183 (1995).
43. Baker TK, Bachowski S, Stevenson DE, Walborg EF Jr, Klaunig JE. Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. Prog Clin Biol Res 391:71-80 (1995).